Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-L- proline and L-isoleucyl-L-prolyl-L-proline): VIII. Assessment of cytotoxicity and clastogenicity of tripeptides-containing casein hydrolysate and Lactobacillus helveticus-fermented milk powders in Chinese hamster lung cells

International Journal of Toxicology

Volumn 24, Issue SUPPL. 4, 2005, Pages 97-105

  Maeno, Masafumi ^a   Mizuno, Seiichi ^a   Mennear, John H ^b   Bernard, Bruce K ^c  

^a CALPIS Co Ltd   (Japan)

^b CAMPBELL UNIVERSITY   (United States)

^c GENERAL DYNAMICS   (United States)

Author keywords

Aspergillus oryzae Protease Casein Hydrolysate; Chinese Hamster Lung Cells; Chromosomal Aberrations; IPP; Lactobacillus helveticus Fermented Milk; VPP

Indexed keywords

BENZO[A]PYRENE; CASEIN HYDROLYSATE; CLASTOGEN; ISOLEUCYLPROLYLPROLINE; MITOMYCIN C; TRIPEPTIDE; UNCLASSIFIED DRUG; VALYLPROLYLPROLINE;

ANIMAL CELL; ARTICLE; CELL GROWTH; CHINESE HAMSTER; CHROMOSOME ABERRATION; CYTOTOXICITY; DRUG ACTIVITY; FERMENTED PRODUCT; LUNG ALVEOLUS CELL; MILK; NONHUMAN; POWDER; TOXICITY TESTING;

ANIMALS; BENZO(A)PYRENE; CASEINS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CHROMOSOME ABERRATIONS; CRICETINAE; CRICETULUS; CULTURED MILK PRODUCTS; DOSE-RESPONSE RELATIONSHIP, DRUG; LACTOBACILLUS HELVETICUS; LUNG; MALE; MICROSOMES, LIVER; MITOMYCIN; MUTAGENICITY TESTS; OLIGOPEPTIDES; POWDERS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; ASPERGILLUS ORYZAE; CRICETULUS GRISEUS; LACTOBACILLUS HELVETICUS;

EID: 27544511405     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/10915810500259663     Document Type: Article

References (14)

1. Aihara, K., O. Kajimoto, H. Hirata, R. Takahashi, and Y. Nakamura. 2005. Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J. Am. Coll. Nutr. 24:257-265.
2. Bernard, B. K., Y. Nakamura, K. Aihara, and J. H. Mennear. 2005a. Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyl-L-proline): IX. Evaluation of the mutagenic potential of synthesized L-valyl-L-prolyl-L-proline in the Salmonella-Escherichia coli/microsome incorporation assay. Int. J. Toxicol. 24(Suppl. 4):107-113.
3. Bernard, B. K., Y. Nakamura, I. Bando, and J. H. Mennear. 2005b. Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyl-L-proline): II. Introduction. Int. J. Toxicol. 24(Suppl. 4):5-11.
4. Ishidate, M., Jr. 1978. Detection of mutagen based on chromosomal aberration [In Japanese.] Mutagen. Toxic. 1:64-73.
5. Kurosaki, T., M. Maeno, J. H. Mennear, and B. K. Bernard. 2005. Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyl-L-proline): VI. Effects of Lactobacillus helveticus-fermented milk powder on fertility and reproductive performance of rats. Int. J. Toxicol. 24(Suppl. 4):61-89.
6. Maeno, M., Y Nakamura, J. H. Mennear, and B. K. Bernard. 2005. Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyl-L-proline): III. Single- and/or repeated-dose toxicity of tripeptides-containing Lactobacillus helveticus-fermented milk powder and casein hydrolysate in rats. Int. J. Toxicol. 24(Suppl. 4):13-23.
7. Matsuoka, A., M. Hayashi, and M. Ishidate Jr. 1979. Chromosomal aberration tests on 29 chemicals combined with S9 mix in vitro. Mutat. Res. 66:277-290.
8. Matsuura, K., J. H. Mennear, M. Maeno, and B. K. Bernard. 2005a. Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyl-L-proline): VII. Micronucleus test of tripeptides- containing casein hydrolysate and Lactobacillus helveticus-fermenled milk powders in rats and mice. Int. J. Toxicol. 24(Suppl. 4):91-96.
9. Matsuura, K., S. Mizuno, S. Nishimura, T. Gotou, and N. Yamamoto. 2005b. Quantitative analysis of antihypertensive peptides Val-Pro-Pro and Ile-Pro-Pro in casein hydrolysate using an Aspergillus oryzae protease an LC-MS method. Milchwissenschaft 60:24-27.
10. Ministry of Health, Labor, and Welfare of Japan. Guideline for genotoxicity studies of drugs. Notification No. 1604 of YAKUSHIN. Dated November 1, 1999.
11. Mizuno, S., J. H. Mennear, K. Matsurra, and B. K. Bernard. 2005. Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyl-L-proline): V. A 13-week toxicity study of tripeptides-containing casein hydrolysate in male and female rats. Int. J. Toxicol. 24(Suppl. 4):41-59.
12. Mizuno, S., S. Nishimura, K. Matsuura, T. Gotou, and N. Yamamoto. 2004. Release of short and proline-rich antihypertensive peptides from casein hydrolysate with an Aspergillus oryzae protease. J. Dairy Sci. 87:3183-3188.
13. Nakamura, Y., I. Bando, J. H. Mennear, and B. K. Bernard. 2005. Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyl-L-proline): IV. Assessment of the repeated-dose toxicological potential of synthesized L-valyl-L-prolyl-L-proline in male and female rats and dogs. Int. J. Toxicol. 24(Suppl. 4):25-39.
14. Working Group on Genotoxicity Studies, the Third Subcommittee of Basic Research Taskforce, the Pharmaceutical Evaluation Committee of the Federation of Pharmaceutical Manufucturers Association (ed.). 2000. Q & A on genotoxicity testing for pharmaceuticals. Scientist Inc., Tokyo.